- emergers.se - Page 6

CRUNCHFISH: Video interview with CEO Joachim Samuelsson on ”the paradigm shift in payments” + feedback from India: ”Scale it up”

2023-02-01• Analys, Research

https://youtu.be/kmv2PDFQQdM Read the press release from Crunchfish here READ EMERGERS’ EQUITY RESEARCH ON CRUNCHFISH HERE CRUNCHFISH:...

Read More →

QLUCORE: Interview with CEO Carl-Johan Ivarsson about the important issues in 2023 and the revenue target of SEK 300 million in 2027

2023-02-01• Analys, Research

READ EMERGERS’ EQUITY RESEARCH ON QLUCORE HERE QLUCORE: At the vanguard of both oncology research and life science M&A With a strong...

Read More →

BONZUN: Evidence-based DTx scaling up to combat stress and infertility

2023-01-24• Analys, Research

We re-initiate coverage on digital therapeutics (DTx) company Bonzun that offers evidence-based patient support for fertility treatments...

Read More →

QLUCORE: At the vanguard of both oncology research and life science M&A

2023-01-20• Analys, Research

With a strong trend in oncology and life science R&D in favour of precision medicine, data analysis and AI, Qlucore is uniquely...

Read More →

NANEXA: Novo Nordisk deal offers both scientific validation and investor-friendly financing

2022-12-23• Analys, Research

The combination of an exclusive evaluation agreement and directed share issue to Novo Nordisk, global leader in diabetes treatment,...

Read More →

KEBNI: Massive order intake for Saab lowers risk in IMU ramp-up markedly

2022-12-19• Analys, Research

In the first half of December, KebNi’s single most important customer, defence company Saab has received two orders for its handheld...

Read More →

CAPSEK | Full effekt, ny weborder och dubblat antal snittkvitton för CapSeks PubQ under 2023

2022-12-08• Okategoriserade

NORTHERN CAPSEK VENTURES CapSeks portföljbolag PubQ erbjuder restauranger ett digitalt restaurangsystem som kan öka snittkvittot med 14...

Read More →

CAPSEK | Stabil underliggande tillväxt för CapSeks onoterade portfölj

2022-12-01• Okategoriserade

NORTHERN CAPSEK VENTURES Trots den bistra utvecklingen i omvärlden så är den operationella utvecklingen i den onoterade delen av...

Read More →

QLUCORE: Structural growth story on track with a slight expansion of long-term scope

2022-11-30• Analys, Research

After the strong growth in Q1’22/23, sales bounced back in Q2’22/23, right in line with our forecast. With the process to CE marking of...

Read More →

KEBNI: New targets reflect high conviction in strong growth across the board in 2023-2027

2022-11-24• Analys, Research

The announcement of KebNi’s revised strategy and financial targets for 2023-2027 reflect a firm conviction in steady long term growth...

Read More →

Författare: johan@emergers.se

CRUNCHFISH: Video interview with CEO Joachim Samuelsson on ”the paradigm shift in payments” + feedback from India: ”Scale it up”

QLUCORE: Interview with CEO Carl-Johan Ivarsson about the important issues in 2023 and the revenue target of SEK 300 million in 2027

BONZUN: Evidence-based DTx scaling up to combat stress and infertility

QLUCORE: At the vanguard of both oncology research and life science M&A

NANEXA: Novo Nordisk deal offers both scientific validation and investor-friendly financing

KEBNI: Massive order intake for Saab lowers risk in IMU ramp-up markedly

CAPSEK | Full effekt, ny weborder och dubblat antal snittkvitton för CapSeks PubQ under 2023

CAPSEK | Stabil underliggande tillväxt för CapSeks onoterade portfölj

QLUCORE: Structural growth story on track with a slight expansion of long-term scope

KEBNI: New targets reflect high conviction in strong growth across the board in 2023-2027

Widmark Research

CONTACT